The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients

详细信息    查看全文

• 作者：Hikaru Hori ; ^{hori-h@med.uoeh-u.ac.jp} ; Reiji Yoshimura ; Asuka Katsuki ; Kenji Hayashi ; Atsuko Ikenouchi-Sugita ; Wakako Umene-Nakano ; Jun Nakamura
• 关键词：Cognitive function ; Schizophrenia ; Risperidone ; Olanzapine ; Aripiprazole ; Dosage ; BACS
• 刊名：Journal of Psychiatric Research
• 出版年：2012
• 出版时间：June, 2012
• 年：2012
• 卷：46
• 期：6
• 页码：757-761
• 全文大小：322 K

文摘

We investigated the effects of the atypical antipsychotics risperidone, olanzapine, and aripiprazole on the cognitive functions of Japanese patients with schizophrenia with respect to dosage amounts and dosing schedules. We performed a cross-sectional survey using the Brief Assessment of Cognition in Schizophrenia - Japanese Language Version (BACS-J) to evaluate the neurocognitive functions of 101 schizophrenic patients who took the same dose of one of the three aforementioned antipsychotics for at least 3 months. The BACS-J composite score correlated negatively with the prescribed dosages of risperidone and olanzapine. In contrast, we did not find a correlation between the BACS-J composite score and the prescribed dosage of aripiprazole. Moreover, the primary scores for verbal learning, motor function, and attention and processing speed were significantly lower among the patients who were taking the prescribed dosage of risperidone. The scores for verbal learning and motor function were also significantly lower when correlated with the prescribed dosage of olanzapine. We did not find a correlation between any of the primary scores on the BACS-J and the prescribed dosage of aripiprazole. In fact, the results suggest there is no linear relationship between the dose of aripiprazole and cognitive impairment, which may be due to its unique pharmacological profile.